The overexpression of β-catenin in high-grade gliomas is a possible outcome of the aberrant activation of the canonical Wnt/β-catenin pathway, which in turn leads to the activation of CCND1 and MYC in gliomas [39]. The gene discussed is MYC; the disease is glioma.